Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
S.F. Group is an Italian pharmaceutical company founded in 2001 and headquartered in Rome, specializing in the development and commercialization of pharmaceuticals, nutraceuticals, and medical devices. The company focuses on several key therapeutic areas, including neurology, orthopedics, gynecology, and urology, providing a diverse portfolio of products such as food supplements and specialized medications. S.F. Group is recognized for its research-driven approach, particularly in the field of physiological modulation, and has developed well-known brands like Tiobec, Kistinox, and Sinergil. While it operates primarily in the Italian market, the company has expanded its reach through strategic collaborations and international distribution. Its business model emphasizes the creation of innovative health solutions that improve patient quality of life through non-invasive therapeutic options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on S.F. Group.